Momeni Arash, Ghaly Mina, Gupta Deepak, Karanas Yvonne L, Kahn David M, Gurtner Geoffrey C, Lee Gordon K
Division of Plastic and Reconstructive Surgery, Stanford University Medical Center.
Eur J Plast Surg. 2013 Oct 1;36(10):633-638. doi: 10.1007/s00238-013-0841-4.
A multitude of different approaches have been proposed for achieving optimal aesthetic results after nipple reconstruction. In contrast, however, only a few studies focus on the morbidity associated with this procedure, particularly after implant-based breast reconstruction.
Using a cross-sectional study design all patients who underwent implant-based breast reconstruction with subsequent nipple reconstruction between 2000 and 2010 at Stanford University Medical Center were identified. The aim of the study was to analyze the impact of the following parameters on the occurrence of postoperative complications: age, final implant volume, time interval from placement of final implant to nipple reconstruction, and history of radiotherapy.
A total of 139 patients with a mean age of 47.5 years (range, 29 to 75 years) underwent 189 nipple reconstructions. The overall complication rate was 13.2 percent (N = 25 nipple reconstructions). No association was observed between age (p = 0.43) or implant volume (p = 0.47) and the occurrence of complications. A trend towards higher complication rates in patients in whom the time interval between final implant placement and nipple reconstruction was greater than 8.5 months was seen (p = 0.07). Radiotherapy was the only parameter that was associated with a statistically significant increase in postoperative complication rate (51.7 percent vs. 6.25 percent; p < 0.00001).
While nipple reconstruction is a safe procedure after implant-based breast reconstruction in patients without a history of radiotherapy, the presence of an irradiated field converts it to a high-risk one with a significant increase in postoperative complication rate. Patients with a history of radiotherapy should be informed about their risk profile and as a result may choose autologous reconstruction instead.
IV.
为在乳头重建后获得最佳美学效果,人们提出了多种不同方法。然而,相比之下,仅有少数研究关注该手术相关的发病率,尤其是在植入式乳房重建术后。
采用横断面研究设计,确定了2000年至2010年间在斯坦福大学医学中心接受植入式乳房重建并随后进行乳头重建的所有患者。该研究的目的是分析以下参数对术后并发症发生情况的影响:年龄、最终植入体体积、从最终植入体放置到乳头重建的时间间隔以及放疗史。
共有139例平均年龄为47.5岁(范围29至75岁)的患者接受了189次乳头重建。总体并发症发生率为13.2%(25次乳头重建)。未观察到年龄(p = 0.43)或植入体体积(p = 0.47)与并发症发生之间存在关联。在最终植入体放置与乳头重建时间间隔大于8.5个月的患者中,有并发症发生率更高的趋势(p = 0.07)。放疗是唯一与术后并发症发生率有统计学显著增加相关的参数(51.7%对6.25%;p < 0.00001)。
对于无放疗史的患者,乳头重建在植入式乳房重建术后是一种安全的手术,但存在放疗区域会使其转变为高风险手术,术后并发症发生率显著增加。有放疗史的患者应被告知其风险状况,因此他们可能会选择自体重建。
IV级